further studies of the amounts and origin of the carbon are needed." "One thing that strikes me about their results is that showing general community stability is . . . precisely what would be predicted if the cryoconite hole environment was like countless others that are studied," says Brent Christner from Louisiana State University in Baton Rouge, who has extensively studied such microbial communities. "Apparently, assemblages of very specifıc organisms have evolved to be extremely competitive under the physical and chemical conditions present, keeping new species arrivals in check. I believe this contributes to our growing appreciation for polar ice sheets as environments for microbial life."
Barry DiGregorio is a freelance writer in Middleport, N.Y.

RESEARCH ADVANCES
Host Signals Can Trigger Virulence in Candida albicans
Shannon Weiman
The virulence of Candida albicans changes in response to signals within and from the host, according to several researchers who spoke during the 28th Fungal Genetics Conference, held in Pacifıc Grove, Calif., last March. In some cases those host signals render this yeast innocuous. In other circumstances, however, C. albicans upregulates virulence factors in response to host signals, becoming an outright pathogen. A recent thrust of research is to reveal those signals that trigger such responses as well as the fungal regulatory pathways that respond to them, with a longer-term goal of combating infections not by killing this yeast, but by blocking virulence.
"C. albicans is the dominant [fungal] commensal of the human gastrointestinal tract, as well as the most common invasive fungal pathogen," says Suzanne Noble of the University of California, San Francisco. In its commensal state, gastrointestinally induced transition (GUT) cells of C. albicans are attenuated for mutualism. However, in its pathogenic invasive "white" form, metabolic and other adaptive changes enable these changed yeast cells to invade the host. This switch of C. albicans is triggered by gut environmental signals and mediated by the Wor1 transcription factor, she says. "The resulting GUT cells differ morphologically and functionally from previously defıned cell types, and express a transcriptome that is optimized for the digestive tract ... exhibiting a striking reorientation of cellular metabolism towards nutrients available in the distal mammalian GI tract."
Carbon dioxide and N-acetylglucosamine are candidate signals from the host controlling this Wor1-induced transcription, Noble continues. "Our results indicate that the ability of a commensal organism to produce disease is not merely a consequence of impaired host immunity. The identifı-cation of specialized states for C. albicans commensalism and virulence offers opportunities for prevention as well as treatment of clinical diseases produced by this important human pathogen." Meanwhile, temperature changes unambiguously can increase the virulence of C. albicans, according to Michelle Leach of the University of Aberdeen in the United Kingdom. When exposed to relatively higher tempera-
MINITOPIC
Microbiology Policy Bulletin Board
Recent national and international developments involving microbiology and related science policy matters include:
• World Health Organization (WHO) officials declared the Ebola virus disease outbreak "over" in Liberia as of 9 May, while noting that the recent total of nine confirmed cases in Sierra Leone and Guinea was the "lowest weekly total this year." • A strain of H5N2 avian influenza virus turned up in Nebraska in May, making it the latest state where this strain was detected in U.S. commercial chicken flocks, affecting more than 37 million birds so far, according to the U.S. Department of Agriculture Animal and Plant Inspection Service (APHIS). APHIS officials also confirm finding a highly pathogenic H5N8 flu strain in a backyard flock in Indiana. Although a huge problem for egg and poultry producers, these strains are not considered a risk for causing disease among humans.
• In May, officials of the Food and Drug Administration (FDA) issued a warning letter to Novartis Animal Health of Greensboro, N.C., now owned by the Elanco unit of Eli Lilly, over its Denagard brand of a feed additive that contains the antibiotic chlortetracycline. FDA reminds the company that the additive is approved only for control of swine dysentery, and warns the company not to advertise the product for promoting growth in animals or for making similar performance claims. The warning comes amid broader agency efforts to curb the improper use of antibiotics in animals. tures such as those encountered when a host develops a fever, C. albicans mounts a heat-shock response, upregulating genes that help to ensure survival but also virulence factors that play no role in its survival, she says. Thus, fever in the host-presumably a response that would disable the pathogen-instead makes it more damaging to the host, Leach fınds, when the moth, Galleria mellonella, is infected by this yeast. "The ability to sense the surrounding temperature is key for virulence," says Leach. "Understanding circuitry governing temperature sensing offers therapeutic opportunities for crippling diverse microbial pathogens." C. albicans senses high temperatures by monitoring membrane fluidity and downregulating the fatty acid biosynthesis gene Ole1, which in turn activates heat shock factor 1 (Hsf1), she and her collaborators fınd. Hsf1 binds to promoter elements, cooperating with heat shock protein 90 (Hsp90) to turn on virulence factors involved in adhesion, biofılm formation, and fılamentation. "Hsf1 and Hsp90 act in concert in the pathogen to combat the host response of fever by upregulating genes necessary for cell survival and continued infection," she says.
Shannon Weiman is a freelance writer in Truckee, Calif.
NEW IN ASM JOURNALS
In Cystic Fibrosis, Iron-Grabbing Pseudomonas Outcompetes S. aureus
David C. Holzman
Of the two major bacterial species that colonize the lungs of cystic fıbrosis (CF) patients, Pseudomonas aeruginosa eventually dominates Staphylococcus aureus. The faster and more fully the former overshadows the latter, the more likely is the host to experience morbidity and mortality, according to George A. O'Toole of the Geisel School of Medicine at Dartmouth University in Hanover, N.H., and his collaborators. That takeover depends in part on the ability of P. aeruginosa to deprive S. aureus of much-needed iron, according to Amanda Oglesby-Sherrouse at the University of Maryland, Baltimore, and her collaborators. Details appeared in separate reports 29 April 2015 in the Journal of Bacteriology (doi:10. 1128/JB.00059 -15 and doi:10.1128/JB. 00072-15, respectively), along with a commentary in that same issue (doi:10. 1128/JB.00303-15 ).
P. aeruginosa drives S. aureus into anaerobic metabolism, slowing the latter's growth while appropriating lactate and iron to accelerate its own growth, according to O'Toole. This process depends on the quorum sensing molecule 4-hydroxy-2-heptylquinolone-N-oxide (HQNO) and two ironbinding molecules, pyoverdine and pyochelin, boosting expression of fermentation pathway genes in S. aureus, he says. This takeover can be followed in vitro by growing these two bacterial species together on a plastic substrate or on airway epithelial cells from individuals with CF, according to O'Toole. Identifying and determining the mechanisms underlying the takeover "are the initial steps to understanding how CF microbial lung communities develop and affect patient health," he says.
When P. aeruginosa steals iron from other bacteria, levels of the molecule it makes called Pseudomonas quinolone signal (PQS) also rise, according to Oglesby-Sherrouse's graduate student Angela Nguyen. During coculture in iron-poor environments, increases in PQS levels plus increases in levels of various 2-alkyl-4(1H)-quinolones
MINITOPIC
Vaccine Update
Recent developments involving vaccines include:
• The Pan American Health Organization/World Health Organization in April declared the Americas the first region in the world to be free of endemic transmission of rubella-culminating a 15-year effort to deploy the measlesmumps-rubella vaccine throughout the 45 countries and territories of North, Central, and South America.
• Use of microneedle patches could make it easier to deliver the measles as well as other vaccines, according to official at the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga., and their collaborators at nearby Georgia Institute of Technology.
• Because measles infections can suppress immune responses for as long as 3 years, the measles vaccine "protects polymicrobial herd immunity" longer than previously believed, helping to explain the long-term benefits of this vaccine, according to Michael Mina of Princeton University in Princeton, N.J., and the School of Medicine at Emory University in Atlanta, and his collaborators. Details appeared 8 May 2015 in Science (doi:10.1126/science.aaa3662).
• A subunit vaccine containing varicella-zoster virus glycoprotein E and the AS01B adjuvant system significantly reduces the risk of herpes zostershingles-in adults 50 -70 years of age, and is about the same for adults older than 70 as is the live-attenuated version of a vaccine to protect against this virus, according to Thomas C. Heineman of GSK Vaccines in King of Prussia, Pa., and his collaborators at several institutions worldwide. Details appeared 28 April 2015 in the New England Journal of Medicine (doi:10.1056/NEJMoa1501184).
